BioAge Labs (BIOA) vs Cypherpunk Technologies (CYPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cypherpunk Technologies (CYPH) has outperformed BioAge Labs (BIOA) over the past year, gaining 387.2% versus a gain of 11.8%. Cypherpunk Technologies is the larger company by market cap ($280.7 million vs $277.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIOA | CYPH |
|---|---|---|
| Share price | $6.04 | $2.61 |
| Market cap | $277.22M | $280.73M |
| 1-day change | -3.51% | -14.62% |
| YTD return | -52.68% | +162.93% |
| 1-year return | +11.79% | +387.22% |
| 5-year return | — | -90.32% |
| P/E ratio (TTM) | — | 4.13 |
| EPS (TTM) | $-2.39 | $0.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $25.96 | $4.19 |
| 52-week low | $5.04 | $0.393 |
| Distance from 52-week high | -76.73% | -37.83% |
| Analyst consensus | none | none |
| Avg. price target upside | +489.90% | +88.10% |
| Average volume | 913.77K | 9.88M |
| Shares outstanding | 45.90M | 107.76M |
| Employees | 60 | 6 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CYPH has outperformed BIOA by 375.4 percentage points over the past year.
About BioAge Labs
BIOA stock →BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging.
Health Care · Biotechnology: Pharmaceutical Preparations · 60 employees
About Cypherpunk Technologies
CYPH stock →Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
BIOA vs CYPH FAQ
Which is bigger, BioAge Labs or Cypherpunk Technologies?
Cypherpunk Technologies (CYPH) is larger, with a market capitalization of $280.73M compared with $277.22M for BioAge Labs (BIOA).
Which stock has performed better over the past year, BIOA or CYPH?
CYPH returned +387.22% over the past 12 months, compared with +11.79% for BIOA (price return, excluding dividends). Past performance does not predict future results.
Are BioAge Labs and Cypherpunk Technologies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.